Almotriptan adverse reactions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
The most common adverse reactions (≥1% and greater than placebo) are: | The most common adverse reactions (≥1% and greater than placebo) are: | ||
* In adults: nausea, dry mouth and paresthesia | * In adults: [[nausea]], [[dry mouth]] and [[paresthesia]] | ||
* In adolescents: dizziness, somnolence, headache, paresthesia, nausea and vomiting | * In adolescents: [[dizziness]], [[somnolence]], [[headache]], [[paresthesia]], [[nausea]] and [[vomiting]] | ||
Revision as of 02:08, 5 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Adverse Reactions
The most common adverse reactions (≥1% and greater than placebo) are:
- In adults: nausea, dry mouth and paresthesia
- In adolescents: dizziness, somnolence, headache, paresthesia, nausea and vomiting